Is SUVmax of F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?

Background: Increasing use of F-FDG PET/CT in cancer patients, has led to more common detection of F- FDG uptake in the gastrointestinal tract (GIT).

Aims: The objective of this study was to assess F-FDG uptake in incidental and known GIT malignancy.

Methods: A total of 6500 patients followed-up in a single and tertiary center between January 2010 and September 2016 were retrospectively reviewed.